Category: Immuno-oncology

F.76 - Low Natural Killer Cells Counts Are Associated with Relapse After Imatinib Discontinuation in Chronic Myeloid Leukemia Patients : The Immunostim Study

Friday, Jun 16
6:15 PM – 7:30 PM

Nicolas Dulphy

INSERM U1160, Université Paris Diderot, APHP, Hôpital Saint-Louis
PARIS, Not Applicable, France

Gabriel Etienne

Service d'Oncologie Médicale, Institut Bergonié, Bordeaux, France.
BORDEAUX, Not Applicable, France

François Guilhot

INSERM CIC 1402, CHU de Poitiers, France.
POITIERS, Not Applicable, France

Joelle Guilhot

INSERM CIC 1402, CHU de Poitiers, France.
POITIERS, Not Applicable, France

Guylaine Henry

INSERM U1160, Université Paris Diderot, APHP, Hôpital Saint-Louis
PARIS, Not Applicable, France

Franck Nicolini

Service d'Hématologie Clinique, CHU Lyon Sud, Pierre Bénite, France.
LYON, Not Applicable, France

Delphine Rea

INSERM U1160, Université Paris Diderot, APHP, Hôpital Saint-Louis
PARIS, Not Applicable, France

Philippe Rousselot

Service d’Hématologie Oncologie et INSERM UMR-1173, Centre Hospitalier de Versailles, Le Chesnay, France.
Le Chesnay, Not Applicable, France

Antoine Toubert

INSERM U1160, Université Paris Diderot, APHP, Hôpital Saint-Louis
Paris, Ile-de-France, France